ACADIAN ASSET MANAGEMENT LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$4,884
-26.2%
1,858,000
-0.9%
0.02%
-25.9%
Q2 2023$6,614
+14.2%
1,874,123
-0.0%
0.03%
+8.0%
Q1 2023$5,792
-24.5%
1,874,859
+3.4%
0.02%
-34.2%
Q4 2022$7,667
-99.8%
1,813,040
-1.4%
0.04%
+58.3%
Q3 2022$4,354,000
-15.5%
1,838,942
+1.7%
0.02%
-7.7%
Q2 2022$5,154,000
+5.9%
1,808,828
+6.9%
0.03%
+30.0%
Q1 2022$4,869,000
-8.2%
1,691,899
-3.1%
0.02%0.0%
Q4 2021$5,305,000
-41.7%
1,746,281
+34.4%
0.02%
-42.9%
Q3 2021$9,106,000
-19.2%
1,299,547
+5.9%
0.04%
-16.7%
Q2 2021$11,270,000
-4.6%
1,227,479
+1.0%
0.04%
-8.7%
Q1 2021$11,814,000
+2.5%
1,215,477
+8.2%
0.05%
+2.2%
Q4 2020$11,527,000
-15.1%
1,123,532
-16.6%
0.04%
-21.1%
Q3 2020$13,582,000
+2.8%
1,346,617
+6.3%
0.06%0.0%
Q2 2020$13,211,000
+78.8%
1,266,931
+44.7%
0.06%
+35.7%
Q1 2020$7,388,000
+0.6%
875,265
+4.3%
0.04%
+27.3%
Q4 2019$7,344,000
+78.5%
839,122
+119.5%
0.03%
+83.3%
Q3 2019$4,114,000
+27.1%
382,201
+50.1%
0.02%
+12.5%
Q2 2019$3,236,000
+1718.0%
254,714
+5456.6%
0.02%
+1500.0%
Q1 2019$178,0004,5840.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders